# Phase II High Dose Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer

> **NCT02960087** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Canadian Cancer Trials Group** · enrollment: 334 (actual)

## Conditions studied

- Prostate Carcinoma

## Interventions

- **RADIATION:** Low dose rate brachytherapy
- **RADIATION:** High dose rate brachytherapy

## Key facts

- **NCT ID:** NCT02960087
- **Lead sponsor:** Canadian Cancer Trials Group
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-03-06
- **Primary completion:** 2029-04-30
- **Final completion:** 2029-10-30
- **Target enrollment:** 334 (ACTUAL)
- **Last updated:** 2026-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02960087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02960087, "Phase II High Dose Brachytherapy and Low Dose Rate Brachytherapy as Monotherapy in Localized Prostate Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02960087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*